A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR)	Bone Diseases, Developmental, Collagen Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, bone disorder, connective tissue disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasia, osteogenesis imperfecta	Recruiting	Phase 2	2026-09-22		NCT07557446

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Angitia Biopharmaceuticals Guangzhou Limited	1

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital of Soochow University	Suzhou	China	2
Chinese Academy of Medical Sciences, Peking Union Medical College Hospital	Beijing	China	2
Shanghai sixth people's hospital	Shanghai	China	31
The Second Xiangya Hospital of Central South University	Changsha	China	3
The University of Hong Kong-Shenzhen Hospital	Shenzhen	China	12